- ►annals.org S Gupta, S Bent, J Kohlwes - Annals of internal medicine, 2003 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add
to Reddit Add to Technorati Add to Twitter What's this? ... Background: Patients with hepatitis C
virus (HCV) are at increased risk ... Cited by 93 - Related articles - BL Direct - All 5 versions
D Sources, D Extraction, D Synthesis - Ann Intern Med, 2003 - palliative.uab.edu Background: Patients with hepatitis C virus (HCV) are at in- creased risk for hepatocellular
carcinoma. Although serum -feto- protein (AFP) is often used to detect hepatocellular carcinoma in
HCV-infected individuals, its ... Related articles - View as HTML
F Trevisani, PE D'Intino, AM Morselli-Labate, G … - Journal of Hepatology, 2001 - Elsevier Results: The best discriminating AFP value was 16 ng/ml. A value of 20 ng/ml (above which
investigations for HCC are recommended) had equivalent sensitivity (60.0 vs. 62.4%) and specificity
(90.6 vs. 89.4%). PPV of 20 ng/ml ... Cited by 182 - Related articles - BL Direct - All 5 versions
J Marrero, GL Su, W Wei, D Emick, HS Conjeevaram, … - Hepatology, 2003 - assets0.pubget.com Mortality due to hepatocellular carcinoma (HCC) has not improved over the last 20 years. This is in
part due to the poor performance of available tumor markers leading to delays in diagnosis.
Des-gamma carboxy-prothrombin (DCP) ... Cited by 138 - Related articles - View as HTML - BL Direct - All 5 versions
M Sherman - Journal of Hepatology, 2001 - Elsevier The use of alphafetoprotein (AFP) serum concentration as a diagnostic test for hepatocellular
carcinoma (HCC) has a long and venerable history. This use arose from the finding that some HCC's
secreted massive amounts of AFP. In ... Cited by 140 - Related articles - BL Direct - All 6 versions
KA Gebo, G Chander, MW Jenckes, KG Ghanem, HF … - Hepatology, 2002 - hawaii.edu This systematic review addresses the following questions: (1) What is the efficacy of using
screening tests for hepatocellular carcinoma (HCC) in improving outcomes in chronic hepatitis C, and
(2) what are the sensitivity and ... Cited by 92 - Related articles - View as HTML - BL Direct - All 6 versions
J Ikoma, M KAITO, T ISHIHARA, N NAKAGAWA, A … - Hepato- …, 2002 - cat.inist.fr Background/Aims: Measurement of des γ-carboxy prothrombin by conventional methods is of limited use
for the early detection of hepatocellular carcinoma for its low sensitivity. The aim of the present
study was to investigate the ... Cited by 30 - Related articles - BL Direct - All 3 versions
JA Marrero - Clinics in liver disease, 2005 - Elsevier The incidence of hepatocellular carcinoma (HCC) is rising throughout the world. HCC meets the
criteria for which a disease benefits from screening or surveillance: it is an important health
problem; those with cirrhosis are ... Cited by 18 - Related articles - All 9 versions
MH Nguyen, RT Garcia, PW Simpson, TL Wright, … - Hepatology, 2002 - interscience.wiley.com -Fetoprotein (AFP) is frequently used as a diagnostic marker for hepatocellular carcinoma (HCC).
Most available data concerning AFP come from studies of patients with chronic hepatitis B or other
chronic liver diseases of mixed ... Cited by 84 - Related articles - BL Direct - All 3 versions
M Ishii, H Gama, N Chida, Y Ueno, H … - … American journal of …, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 66 - Related articles - BL Direct - All 7 versions
